share_log

来凯医药-B(02105.HK)向承授人授出合共1124万份受限制股份单位

Lai Kai Pharmaceuticals-B (02105.HK) has granted a total of 11.24 million restricted share units to the grantee.

Gelonghui Finance ·  Sep 5 05:26

On September 5, 2024, Lai Kai Medicine-B (02105.HK) announced that it will grant a total of 11.24 million restricted share units (equivalent to a total of 11.24 million shares) under the 2024 share incentive plan to the grantee (including three executive directors). The grant of restricted share units to the three executive directors, including Lv Xiangyang, Xie Ling, and Gu Xiangju, must be approved by independent shareholders at a special general meeting of shareholders before it can take effect.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment